Recombinant neurotrophin-3 with the ability to penetrate the blood-brain barrier: A new strategy against Alzheimer's disease

Autor: Ding, Xuying ^{a, 1}, Zuo, YuanYuan ^{a, 1}, Liu, Zhenye ^a, Sun, Yunwei ^b, Wang, Leiyi ^c, Xie, Yining ^a, Liu, Guohan ^a, Liu, Chang ^{a, ⁎}

Publikováno v: In International Journal of Biological Macromolecules March 2025 293

Biological effects and mechanism of β-amyloid aggregation inhibition by penetrable recombinant human HspB5-ACD structural domain protein

Autor: Liu, Chang, Ding, Xuying, Zhao, Meijun, Chen, Chen, Zhang, Xiaojun, Zhao, Risheng, Chen, Yutong, Xie, Yining

Publikováno v: In Biomedicine & Pharmacotherapy June 2024 175

Recombinant human HspB5-ACD structural domain inhibits neurotoxicity by regulating pathological α-Syn aggregation

Autor: Liu, Chang, Ding, Xuying, Guo, Xiao, Zhao, Meijun, Zhang, Xiaojun, Li, Ziqing, Zhao, Risheng, Cao, Yuyan, Xing, Jiaying

Publikováno v: In International Journal of Biological Macromolecules January 2024 255

Recombinant neurotrophin-3 with the ability to penetrate the blood-brain barrier: A new strategy against Alzheimer's disease.

Autor: Ding X; College of Pharmacy, Beihua University, Jilin, Jilin 132013, PR China., Zuo Y; College of Pharmacy, Beihua University, Jilin, Jilin 132013, PR China., Liu Z; College of Pharmacy, Beihua University, Jilin, Jilin 132013, PR China., Sun Y; Department of Endocrinology, Jilin University Second Hospital, Changchun, Jilin 130022, PR China., Wang L; State key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Changchun, Jilin 130022, PR China., Xie Y; College of Pharmacy, Beihua University, Jilin, Jilin 132013, PR China., Liu G; College of Pharmacy, Beihua University, Jilin, Jilin 132013, PR China., Liu C; College of Pharmacy, Beihua University, Jilin, Jilin 132013, PR China. Electronic address: liuchangbhu@163.com.

Publikováno v: International journal of biological macromolecules [Int J Biol Macromol] 2024 Dec 30, pp. 139359. Date of Electronic Publication: 2024 Dec 30.